Ángel Martínez-Agulló

Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer

Luca Gianni, José Baselga, W. Eiermann et al. · Journal of Clinical Oncology · 2009 · 216 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients

Amelia Insa, Aňa Lluch, Felipe Prósper et al. · Breast Cancer Research and Treatment · 1999 · 190 citations

Medicine, Biostatistics, Oncology +16

Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy

Luca Gianni, José Baselga, W. Eiermann et al. · Clinical Cancer Research · 2005 · 165 citations

Medicine, Oncology, Pharmacology +15

Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?

José Alejandro Pérez Fidalgo, Paola Pimentel, Antonio Díaz Caballero et al. · The Breast · 2011 · 57 citations · Full text

Medicine, Oncology, Surgery +17

Factors associated with health-related quality of life in a cohort of Spanish breast cancer patients

David Moro‐Valdezate, Elvira Buch-Villa, Salvador Peiró et al. · Breast Cancer · 2012 · 33 citations · Full text

Medicine, Health Sciences, Oncology +11